APELLIS PHARMACEUTICALS INC (APLS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for APLS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| APLS | President and Chief Executive Officer | 52 | ["Co-Founder, President and Chief Executive Officer, Apellis (2009 \u2013 present)", "Co-Founder, President and Chief Executive Officer, Potentia Pharmaceuticals, Inc. (private, 2001 \u2013 2018)", "Co-Founder, Revon Systems, LLC (Revon), a private healthcare software company (2014 \u2013 2019)", "Member of the research team that performed the first successful hand transplantation", "Member of the Louisville Face Transplant Team"] | [] | 2025 |
Biography sourced from the proxy statement filing.
President and Chief Executive Officer Director since 2009 Age: 52 Experience Co-Founder, President and Chief Executive Officer, Apellis (2009 present) Co-Founder, President and Chief Executive Officer, Potentia Pharmaceuticals, Inc. (private, 2001 2018) Co-Founder, Revon Systems, LLC (Revon), a private healthcare software company (2014 2019) Following postgraduate training in pediatric and transplant surgery, was a member of the research team that performed the first successful hand transplantation and of the Louisville Face Transplant Team, whose work supported hand transplantation in Lyon, France Qualifications Expertise and extensive leadership experience in immunology and immune system-mediated diseases Extensive knowledge of our company based on his role as co-founder and Chief Executive Officer Education M.D., University of Leuven (Belgium) Ph.D., Physiology, University of Louisville Other Boards Liberate Medical, Inc. (private, 2016 present) Acuamark Diagnostics (private, 2021 present) Potentia Pharmaceuticals (private, 2001 2018) Revon Systems (private, 2014 2019)